CN117083054A - 用于治疗过敏反应的装置 - Google Patents

用于治疗过敏反应的装置 Download PDF

Info

Publication number
CN117083054A
CN117083054A CN202280024727.6A CN202280024727A CN117083054A CN 117083054 A CN117083054 A CN 117083054A CN 202280024727 A CN202280024727 A CN 202280024727A CN 117083054 A CN117083054 A CN 117083054A
Authority
CN
China
Prior art keywords
epinephrine
dose inhaler
formulation
metered dose
pressurized metered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280024727.6A
Other languages
English (en)
Chinese (zh)
Inventor
G·H·卢修克
A·R·马丁
C·A·鲁兹奇
W·H·芬莱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
1232176 BC Ltd
Original Assignee
1232176 BC Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 1232176 BC Ltd filed Critical 1232176 BC Ltd
Publication of CN117083054A publication Critical patent/CN117083054A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C19/00—Acyclic saturated compounds containing halogen atoms
    • C07C19/08—Acyclic saturated compounds containing halogen atoms containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/02—Equipment for testing the apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Processing Of Meat And Fish (AREA)
  • Surgical Instruments (AREA)
  • Non-Portable Lighting Devices Or Systems Thereof (AREA)
CN202280024727.6A 2021-03-23 2022-03-23 用于治疗过敏反应的装置 Pending CN117083054A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163165102P 2021-03-23 2021-03-23
US63/165,102 2021-03-23
PCT/US2022/021612 WO2022204328A1 (en) 2021-03-23 2022-03-23 Device for treating anaphylaxis

Publications (1)

Publication Number Publication Date
CN117083054A true CN117083054A (zh) 2023-11-17

Family

ID=81307871

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280024727.6A Pending CN117083054A (zh) 2021-03-23 2022-03-23 用于治疗过敏反应的装置

Country Status (20)

Country Link
US (1) US20220331237A1 (cg-RX-API-DMAC7.html)
EP (2) EP4188332B1 (cg-RX-API-DMAC7.html)
JP (2) JP2024515446A (cg-RX-API-DMAC7.html)
KR (1) KR20230165764A (cg-RX-API-DMAC7.html)
CN (1) CN117083054A (cg-RX-API-DMAC7.html)
AU (1) AU2022245300B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023019156A2 (cg-RX-API-DMAC7.html)
CA (1) CA3212189A1 (cg-RX-API-DMAC7.html)
DK (1) DK4188332T3 (cg-RX-API-DMAC7.html)
ES (2) ES3025005T3 (cg-RX-API-DMAC7.html)
FI (1) FI4188332T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20250566T1 (cg-RX-API-DMAC7.html)
HU (1) HUE071185T2 (cg-RX-API-DMAC7.html)
IL (1) IL305534A (cg-RX-API-DMAC7.html)
LT (1) LT4188332T (cg-RX-API-DMAC7.html)
PL (1) PL4188332T3 (cg-RX-API-DMAC7.html)
PT (1) PT4188332T (cg-RX-API-DMAC7.html)
RS (1) RS66787B1 (cg-RX-API-DMAC7.html)
SI (1) SI4188332T1 (cg-RX-API-DMAC7.html)
WO (1) WO2022204328A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12514995B2 (en) * 2021-02-15 2026-01-06 Glenmark Pharmaceuticals Limited Metered dose inhalers of fluticasone or an ester thereof
WO2025072756A1 (en) * 2023-09-28 2025-04-03 Kokua Pharma Inc. Device, methods, and uses for treating acute allergic reactions
WO2025170986A1 (en) * 2024-02-06 2025-08-14 Kindeva Drug Delivery L.P. Drug delivery device
US20260007598A1 (en) * 2024-07-05 2026-01-08 Honeywell International Inc. Compositions, devices and methods for respritory delivery of active pharmaceutical ingredients
US12496272B1 (en) * 2024-07-31 2025-12-16 Amphastar Pharmaceuticals, Inc. Stable epinephrine suspension formulation for inhalation with HFO propellant

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009095681A2 (en) * 2008-02-01 2009-08-06 Vectura Limited Suspension formulations
CN101502500A (zh) * 2002-03-01 2009-08-12 奇斯药制品公司 含有β2-激动剂的溶液的加压计量吸入器
CN101553209A (zh) * 2006-10-24 2009-10-07 阿拉迪姆公司 提供立即释放模式和持续释放模式双重作用的吸入制剂
CN110505873A (zh) * 2018-02-06 2019-11-26 爱奇司治疗公司 鼻内肾上腺素制剂及治疗疾病的方法
CN112153966A (zh) * 2018-03-19 2020-12-29 布莱恩制药有限责任公司 肾上腺素喷雾制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9324250D0 (en) * 1993-11-25 1994-01-12 Minnesota Mining & Mfg Inhaler
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
EP1531794B1 (en) * 2002-06-28 2017-05-10 Civitas Therapeutics, Inc. Inhalable epinephrine
AU2004249166B2 (en) * 2003-06-13 2008-10-09 Alkermes, Inc. Low dose pharmaceutical powders for inhalation
WO2006101882A2 (en) * 2005-03-16 2006-09-28 Honeywell International Inc. Medicament delivery formulations, devices and methods
US8367734B1 (en) * 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
SI2627386T1 (sl) * 2010-10-12 2015-10-30 Ivax Pharmaceuticals Ireland Nosna pršilna naprava
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
WO2014033057A1 (en) * 2012-08-29 2014-03-06 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
US10039710B2 (en) * 2015-09-18 2018-08-07 Insys Development Company, Inc. Epinephrine spray formulations
US9717683B1 (en) * 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101502500A (zh) * 2002-03-01 2009-08-12 奇斯药制品公司 含有β2-激动剂的溶液的加压计量吸入器
CN101553209A (zh) * 2006-10-24 2009-10-07 阿拉迪姆公司 提供立即释放模式和持续释放模式双重作用的吸入制剂
WO2009095681A2 (en) * 2008-02-01 2009-08-06 Vectura Limited Suspension formulations
CN110505873A (zh) * 2018-02-06 2019-11-26 爱奇司治疗公司 鼻内肾上腺素制剂及治疗疾病的方法
CN112153966A (zh) * 2018-03-19 2020-12-29 布莱恩制药有限责任公司 肾上腺素喷雾制剂

Also Published As

Publication number Publication date
KR20230165764A (ko) 2023-12-05
JP2024515446A (ja) 2024-04-10
EP4188332A1 (en) 2023-06-07
EP4188332B1 (en) 2025-02-12
ES3025005T3 (en) 2025-06-05
RS66787B1 (sr) 2025-06-30
EP4545122C0 (en) 2026-07-15
AU2022245300A1 (en) 2023-09-14
IL305534A (en) 2023-10-01
CA3212189A1 (en) 2022-09-29
PL4188332T3 (pl) 2025-11-24
LT4188332T (lt) 2025-05-12
EP4545122A2 (en) 2025-04-30
WO2022204328A1 (en) 2022-09-29
SI4188332T1 (sl) 2025-07-31
FI4188332T3 (fi) 2025-05-06
HUE071185T2 (hu) 2025-08-28
JP2026094267A (ja) 2026-06-09
HRP20250566T1 (hr) 2025-06-20
ES3076082T3 (en) 2026-08-11
EP4545122A3 (en) 2025-05-07
DK4188332T3 (da) 2025-05-05
US20220331237A1 (en) 2022-10-20
PT4188332T (pt) 2025-04-17
BR112023019156A2 (pt) 2023-10-17
AU2022245300B2 (en) 2026-04-02
EP4545122B1 (en) 2026-07-15

Similar Documents

Publication Publication Date Title
AU2022245300B2 (en) Device for treating anaphylaxis
EP3384931B1 (en) Formoterol superfine formulation
ES2774391T3 (es) Composiciones, métodos y sistemas para la administración respiratoria de dos o más agentes activos
JP5791166B2 (ja) チオトロピウムを含む吸入可能な薬剤
CN103052378A (zh) 包含磷酸二酯酶抑制剂的药物制剂
ZA200406919B (en) Formoterol superfine formulation
HK1221654A1 (zh) 用於呼吸递送三种或更多种活性剂的组合物、方法和系统
EP1415647A1 (en) "Long-acting beta-2 agonists ultrafine formulations"
TWI449523B (zh) 福莫特羅(formoterol)及二丙酸倍氯米松(beclometasone dipropionate)之醫藥噴霧劑配方
HK40087057A (en) Device for treating anaphylaxis
HK40087057B (en) Device for treating anaphylaxis
HK40102631A (en) Device for treating anaphylaxis
WO2025072756A1 (en) Device, methods, and uses for treating acute allergic reactions
WO2014133410A1 (ru) Аэрозольный препарат на основе ипратропия бромида для лечения заболеваний органов дыхания
CA2872569C (en) Uses of antagonists of hyaluronan signaling
Hindle Aerosol drug delivery
HK1079425B (zh) 福莫特罗超细制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40102631

Country of ref document: HK

CB02 Change of applicant information
CB02 Change of applicant information

Country or region after: Canada

Address after: British Columbia

Applicant after: Koukua Pharmaceutical Co.,Ltd.

Address before: British Columbia

Applicant before: 1232176 B.C. Ltd.

Country or region before: Canada